An interventional study of Non Invasive vagus nerve stimulation in Dysphagia Following Cerebrovascular Accident, sponsored by Campus Bio-Medico University. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-14.
Sponsored by Campus Bio-Medico University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Deglutition Disorders with a site in Italy — 11 open to participants now, 12 under way, none of them phase 3. Deglutition Disorders · Italy.
Among the 27 studies in Deglutition Disorders with a site in Italy, this one is the 11th largest by planned enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2024, is one of 14 with no phase, reaches primary completion later than 3 of the 11 other live ones, and was the 22nd registered.
875 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.
Browse Deglutition Disorders studies →11 of the 27 studies in Deglutition Disorders with a site in Italy are open now. Recruiting first, the newest first:
IRCCS San Camillo, Venezia, Italy · Sites in Italy
Ages 18–85
IRCCS Centro Neurolesi Bonino Pulejo · Sites in Italy
Ages 45–85
Istituto Auxologico Italiano · Sites in Italy
Ages 18+
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18+ · Healthy volunteers
IRCCS San Camillo, Venezia, Italy · Sites in Italy
Ages 18–89
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 137 Deglutition Disorders studies recruiting now, 75 (55%) set no upper age limit and 26 (19%) stop at 75 or younger; 15 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 4 started in 2024.
This study's planned enrollment of 30 is below the median of 60 across 581 interventional studies indexed under Deglutition Disorders.
Median enrollment 60 across the 15 interventional studies, 101 across the 12 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 27 have an industry lead sponsor. The 10 most frequent:
Campus Bio-Medico University is the lead sponsor of 84 studies on the registry; 11 are open to participants now.
Campus Bio-Medico University has 1 study filed under Deglutition Disorders — fewer than ten, so there is no comparison to draw.
2 of the studies in Deglutition Disorders with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06296420Istituto Auxologico ItalianoDysphagia After Thyroidectomy | 2026-11-30 |
| NCT07708467Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoThe DiNAM-EoE-C Study: Esophageal Distensibility and Novel Assessment of Motility in Eosinophilic Esophagitis | 2027-08-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 27 studies in Deglutition Disorders with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of the present project is to use transcutaneous auricular vagus nerve stimulation (t-VNS) for the treatment of dysphagia in acute stroke patients to improve swallowing function and reduce mortality and disability related to this condition.
30 patients will be randomized into one of the two arms of the study:
Swallowing function and clinical conditions will be evaluated before the intervention (baseline, T0), immediately after the intervention (T1) and 3 months after the intervention (T2).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
real t-VNS on left ear for 40 minutes, daily for 3 consecutive days, simultaneously with speech therapy.
Device: Non Invasive vagus nerve stimulation
sham t-VNS on left ear for 40 minutes, daily for 3 consecutive days, simultaneously with speech therapy.
Device: Non Invasive vagus nerve stimulation
Transcutaneous Auricular Vagus Nerve Stimulation
Swallowing function
Swallowing video fluoroscopic will be used to measure swallowing function
Time frame: Baseline, Immediately after intervention
Disability
Disability will be measured by mRS and the necessity of nasogastric tube/gastrostomy.
Time frame: Baseline, Immediately after intervention, 3 months after intervention
Mortality
Number of deaths
Time frame: Baseline, Immediately after intervention, 3 months after intervention
Morbidity
Number of aspiration pneumonia
Time frame: Baseline, Immediately after intervention, 3 months after intervention
Swallowing function
Swallowing video fluoroscopic will be used to measure swallowing function
Time frame: Baseline, 3 months after intervention
Plan to share: Undecided
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Dec 2025, 13 months after the start.
Of 290 non-industry interventional studies with no phase under Deglutition Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 13 months is below that.
Counting every sponsor, half of 299 studies reached it within 21 months; a quarter within 10 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Campus Bio-Medico University